EPAS1 and glioblastoma: GBM cells show an increase in cisplatin resistance after exposure to hypoxia, and downregulating HIF2α, not HIF1α, significantly sensitizes U251 and U87 cells (GBM cell lines) to cisplatin (Ahmed et al., 2018).